BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9163877)

  • 1. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA.
    Löhr CV; Teifke JP; Failing K; Weiss E
    Vet Pathol; 1997 May; 34(3):212-21. PubMed ID: 9163877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
    Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
    J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular proliferative and telomerase activity in canine mammary gland tumors.
    Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
    Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of proliferative activity of thyroid Hürthle cell tumors using PCNA, Ki-67 and AgNOR methods.
    Augustynowicz A; Dziecioł J; Barwijuk-Machała M; Dadan J; Puchalski Z; Sulkowski S
    Folia Histochem Cytobiol; 2004; 42(3):165-8. PubMed ID: 15493577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on nucleolar organiser regions (AgNors) in selected spontaneous and transplantable animal tumors.
    Dzimira S; Madej JA; Nowak M
    Pol J Vet Sci; 2005; 8(2):127-35. PubMed ID: 15989132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
    Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
    J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric analysis of AgNORs in tubular and papillary parts of canine mammary gland tumors.
    Juntes P; Pogacnik M
    Anal Quant Cytol Histol; 2000 Jun; 22(3):185-92. PubMed ID: 10872033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of argyrophilic nucleolar organizer regions by counting and image analysis in canine mammary tumors.
    Destexhe E; Vanmanshoven P; Coignoul F
    Am J Vet Res; 1995 Feb; 56(2):185-7. PubMed ID: 7717583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of nucleoli and nucleolar organizer regions per nucleus and nucleolus--prognostic value in canine mammary tumors.
    Bratulić M; Grabarević Z; Artuković B; Capak D
    Vet Pathol; 1996 Sep; 33(5):527-32. PubMed ID: 8885179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
    Botticelli AR; Casali AM; Botticelli L; Zaffe D
    Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
    Gulbahar MY; Yuksel H; Guvenc T; Okut H
    Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B; Bethwaite PB; Thornton A; Ribas JL
    Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of proliferation activity in human CNS tumours: the determination of AgNOR, PCNA and Ki-67 expression. Part 1: AgNOR expression in CNS tumours.
    Janczukowicz J
    Folia Neuropathol; 2003; 41(2):97-101. PubMed ID: 12899202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
    Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
    Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between PCNA expression and AgNOR dots in pituitary adenomas.
    Klencki M; Kurnatowska I; Słowińska-Klencka D; Lewiński A; Pawlikowski M
    Endocr Pathol; 2001; 12(2):163-9. PubMed ID: 11579682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
    Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
    Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours.
    Preziosi R; Sarli G; Benazzi C; Marcato PS
    J Comp Pathol; 1995 Nov; 113(4):301-13. PubMed ID: 8746954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
    Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
    Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.